CONTRAFECT Corp
CFRXDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001478069
CONTRAFECT Corp was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Feb 16, 2023; 40 institutions reported holding it in 13F filings for Q4 2022, worth $1.08M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in CONTRAFECT Corp as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CFRX is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 0
- −1 vs. Q3 2024
- Shares held
- 0
- −6 (−100.0%) vs. Q3 2024
- Total value
- $0
- $0 vs. Q3 2024
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $440 |
| Q3 2023 | 19 | $338.8K |
| Q2 2023 | 16 | $183.0K |
| Q1 2023 | 19 | $433.1K |
| Q4 2022 | 40 | $1.08M |
| Q3 2022 | 46 | $1.49M |
| Q2 2022 | 53 | $71.4M |
| Q1 2022 | 52 | $84.4M |
| Q4 2021 | 59 | $61.3M |
| Q3 2021 | 56 | $93.3M |
| Q2 2021 | 67 | $104.2M |
| Q1 2021 | 80 | $124.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding CONTRAFECT Corp; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Old Point Trust & Financial Services N A | 0 | $0 | 0.00% | −6−100.0% | Sold out |